BSE Live
Sep 24, 16:01Prev. Close
51.91
Open Price
51.73
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Sep 24, 15:57Prev. Close
51.97
Open Price
51.81
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
50.81 (1393)
Key Financial Ratios of Morepen Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | 2.20 | 1.88 | 0.77 | 2.26 | 2.16 | |
Diluted EPS (Rs.) | 2.20 | 1.88 | 0.77 | 1.96 | 2.16 | |
Cash EPS (Rs.) | 2.68 | 2.55 | 1.30 | 2.71 | 2.83 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 21.10 | 16.58 | 14.72 | 12.10 | 9.43 | |
Book Value [InclRevalReserve]/Share (Rs.) | 21.10 | 16.58 | 14.72 | 12.10 | 9.43 | |
Revenue from Operations/Share (Rs.) | 33.06 | 33.07 | 27.73 | 32.37 | 26.41 | |
PBDIT/Share (Rs.) | 3.51 | 3.38 | 1.68 | 3.08 | 2.90 | |
PBIT/Share (Rs.) | 2.98 | 2.72 | 1.13 | 2.50 | 2.23 | |
PBT/Share (Rs.) | 2.83 | 2.65 | 1.09 | 2.65 | 2.19 | |
Net Profit/Share (Rs.) | 2.15 | 1.89 | 0.76 | 2.13 | 2.16 | |
NP After MI And SOA / Share (Rs.) | 2.15 | 1.88 | 0.76 | 2.13 | 2.16 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 10.62 | 10.21 | 6.04 | 9.50 | 10.99 | |
PBIT Margin (%) | 9.02 | 8.23 | 4.07 | 7.71 | 8.44 | |
PBT Margin (%) | 8.56 | 8.01 | 3.93 | 8.19 | 8.29 | |
Net Profit Margin (%) | 6.51 | 5.71 | 2.72 | 6.57 | 8.17 | |
NP After MI And SOA Margin (%) | 6.51 | 5.68 | 2.72 | 6.57 | 8.17 | |
Return on Networth/Equity (%) | 10.20 | 11.34 | 5.13 | 17.57 | 22.85 | |
Return on Capital Employed (%) | 12.79 | 15.61 | 7.31 | 19.44 | 22.07 | |
Return on Assets (%) | 6.63 | 7.43 | 3.48 | 9.50 | 11.31 | |
Total Debt/Equity (X) | 0.07 | 0.03 | 0.03 | 0.03 | 0.04 | |
Asset Turnover Ratio (%) | 1.18 | 1.41 | 1.30 | 1.60 | 138.44 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 2.32 | 2.21 | 2.35 | 1.61 | 1.30 | |
Quick Ratio (X) | 1.72 | 1.59 | 1.64 | 1.00 | 0.87 | |
Inventory Turnover Ratio (X) | 6.60 | 3.70 | 3.10 | 3.53 | 6.78 | |
Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Coverage Ratios | ||||||
Interest Coverage Ratios (%) | 23.07 | 46.52 | 43.25 | -19.96 | 73.02 | |
Interest Coverage Ratios (Post Tax) (%) | 23.07 | 46.52 | 43.25 | -19.96 | 73.02 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 2,682.56 | 2,126.72 | 1,280.99 | 1,720.86 | 1,393.88 | |
EV/Net Operating Revenue (X) | 1.48 | 1.26 | 0.90 | 1.11 | 1.17 | |
EV/EBITDA (X) | 13.94 | 12.32 | 14.95 | 11.71 | 10.67 | |
MarketCap/Net Operating Revenue (X) | 1.45 | 1.27 | 0.93 | 1.13 | 1.22 | |
Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Price/BV (X) | 2.27 | 2.54 | 1.74 | 3.02 | 3.40 | |
Price/Net Operating Revenue | 1.45 | 1.27 | 0.93 | 1.13 | 1.22 | |
Earnings Yield | 0.05 | 0.04 | 0.03 | 0.06 | 0.07 |
12.08.2025
Morepen Lab Consolidated June 2025 Net Sales at Rs 425.24 crore, down 6.59% Y-o-Y
07.08.2025
Morepen Lab Standalone June 2025 Net Sales at Rs 391.28 crore, up 1.46% Y-o-Y
13.05.2025
Morepen Lab Standalone March 2025 Net Sales at Rs 381.94 crore, down 2.72% Y-o-Y
12.05.2025
Morepen Lab Consolidated March 2025 Net Sales at Rs 465.85 crore, up 10.11% Y-o-Y